title: Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
authors.affiliation: Service de Néphrologie Hôpital de Bicetre, Université Paris-Sud, France.
authors.forename: C
authors.initials: C
authors.lastname: Hiesse
authors.forename: J P
authors.initials: JP
authors.lastname: Gardin
authors.forename: O
authors.initials: O
authors.lastname: Lantz
authors.forename: M
authors.initials: M
authors.lastname: Cantarovich
authors.forename: H
authors.initials: H
authors.lastname: Bensadoun
authors.forename: G
authors.initials: G
authors.lastname: Benoit
authors.forename: J
authors.initials: J
authors.lastname: Bellamy
authors.forename: M
authors.initials: M
authors.lastname: Paillard
authors.forename: B
authors.initials: B
authors.lastname: Charpentier
authors.forename: D
authors.initials: D
authors.lastname: Fries
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D016030:Kidney Transplantation; D007684:Kidney Tubules / Q000187:drug effects / Q000502:physiology
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine